Erika Check Hayden is an award-winning, San Francisco-based science and technology reporter. She writes for Nature, and on a freelance basis for a variety of publications, and is a lecturer in the University of California, Santa Cruz Science Communication Program.
Erika Check Hayden
Freelance writer
From this contributor
For studies, size matters: Let us count the ways
In autism research, as in other fields, small sample sizes can lead to false findings. The size of the sample needed for statistical significance depends on the type of study.
For studies, size matters: Let us count the ways
By
Erika Check Hayden
17 October 2018 | 6 min read
Preprint server bioRxiv gets boost from Facebook billionaire
The Chan Zuckerberg Initiative has pledged to provide financial support for bioRxiv, a website where researchers can share manuscripts before peer review.
Preprint server bioRxiv gets boost from Facebook billionaire
By
Erika Check Hayden
28 April 2017 | 5 min read
Book review: ‘Rigor Mortis’ reveals rampant sloppiness in science
In his new book, journalist Richard Harris writes that lack of reproducibility in research poses a serious threat to science.
Book review: ‘Rigor Mortis’ reveals rampant sloppiness in science
By
Erika Check Hayden
4 April 2017 | 5 min read
Rising star: Somer Bishop fine-tunes autism diagnosis
Somer Bishop is launching a revolution in autism diagnosis, creating faster, more precise tools that speed research and better capture the full spectrum of autism symptoms.
Rising star: Somer Bishop fine-tunes autism diagnosis
By
Erika Check Hayden
28 April 2016 | 8 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read